Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
To determine whether the presenilin 1 (PS1), presenilin 2 (PS2) and amyloid beta-protein precursor (APP) mutations linked to familial Alzheimer's disease (FAD) increase the extracellular concentration of amyloid beta-protein (A beta) ending at A beta 42(43) in vivo, we performed a blinded comparison of plasma A beta levels in carriers of these mutations and controls. A beta 1-42(43) was elevated in plasma from subjects with FAD-linked PS1 (P < 0.0001), PS2N1411 (P = 0.009), APPK670N,M671L (P < 0.0001), and APPV7171 (one subject) mutations. A beta ending at A beta 42(43) was also significantly elevated in fibroblast media from subjects with PS1 (P < 0.0001) or PS2 (P = 0.03) mutations. These findings indicate that the FAD-linked mutations may all cause Alzhelmer's disease by increasing the extracellular concentration of A beta 42(43), thereby fostering cerebral deposition of this highly amyloidogenic peptide.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ is produced by sequential β- and γ-secretase proteolytic cleavage of the amyloid precursor protein (APP) [11–17].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [11]
In the citing paper
“Similar to PSEN1 , PSEN2 mutations may also cause increased production of long A 𝛃 peptide species (481, 523), although this needs more investigation.”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [523]
In the citing paper
“It is well established that this mutation causes concomitant increases in secreted A42 and A40 (Cai et al., 1993;Citron et al., 1994;Scheuner et al., 1996).”
From Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease (2001) · cites this paper as Scheuner et al., 1996
In the citing paper
“In a previous study of human plasma (Scheuner et al., 1996), we showed that the Swedish APP K670N,M671L mutation increases both A42 and A40 and that other FAD-linked APP, PS1, and PS2 mutations selectively increase A42.”
From Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease (2001) · cites this paper as Scheuner et al., 1996
In the citing paper
“In that report, we suggested that cerebral A deposition in FAD occurs because of an increase in CNS A that develops as part of a generalized genetic effect that also increases plasma A.”
From Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease (2001) · cites this paper as Scheuner et al., 1996
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Self-citationCloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Self-citationCandidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Self-citationJarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052
Self-citationJarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Self-citationCitron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
Self-citationIsolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Self-citation
Cited by
Items 2,501–2,576 of 2,576
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612333
Sanchez, J. S., Hanseeuw, B. J., Lopera, F., Sperling, R. A., Baena, A. Y., Bocanegra, Y., Aguillon, D., Guzmán‐Vélez, E., Pardilla‐Delgado, E., Ramirez-Gomez, L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13585302
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612327
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612324
Wang, M., Lv, J., Huang, X., Wisniewski, T., & Zhang, W. (2021) · Figshare · doi:10.6084/m9.figshare.16530212
Sanchez, J. S., Hanseeuw, B. J., Lopera, F., Sperling, R. A., Baena, A. Y., Bocanegra, Y., Aguillon, D., Guzmán‐Vélez, E., Pardilla‐Delgado, E., Ramirez-Gomez, L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13585296
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612348
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612330
GXGD-Type Intramembrane Proteases
Steiner, H., & Haass, C. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6311-4_3
Galasko, D., Farlow, M. R., Lucey, B. P., Honig, L. S., Elbert, D. L., Bateman, R. J., Momper, J., Thomas, R. G., Rissman, R. A., Pa, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26743661
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612345
Sanchez, J. S., Hanseeuw, B. J., Lopera, F., Sperling, R. A., Baena, A. Y., Bocanegra, Y., Aguillon, D., Guzmán‐Vélez, E., Pardilla‐Delgado, E., Ramirez-Gomez, L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13585305
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612342
Vasciaveo, V., Iadarola, A., Casile, A., Dante, D., Morello, G., Minotta, L., Tamagno, E., Cicolin, A., & Guglielmotto, M. (2024) · Figshare · doi:10.6084/m9.figshare.26562571
Sanchez, J. S., Hanseeuw, B. J., Lopera, F., Sperling, R. A., Baena, A. Y., Bocanegra, Y., Aguillon, D., Guzmán‐Vélez, E., Pardilla‐Delgado, E., Ramirez-Gomez, L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13585308
Additional file 1 of Aβ43 aggregates exhibit enhanced prion-like seeding activity in mice
Ruiz‐Riquelme, A., Mao, A., Barghash, M. M., Lau, H. H. C., Stuart, E., Kovacs, G. G., Nilsson, K. P. R., Fraser, P. E., Schmitt‐Ulms, G., & Watts, J. C. (2021) · Figshare · doi:10.6084/m9.figshare.14570473
Sanchez, J. S., Hanseeuw, B. J., Lopera, F., Sperling, R. A., Baena, A. Y., Bocanegra, Y., Aguillon, D., Guzmán‐Vélez, E., Pardilla‐Delgado, E., Ramirez-Gomez, L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13585299
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612339
Spanou, S., Vogiatzoglou, A. P., Papanikolaou, S., Maria, P., Pandi, I., Makatounakis, T., Deligianni, E., Tzanos, D., Nikolaou, C., Poirazi, P., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-04088-4
Konstantoulea, K., Ramakers, M., Borrie, S. C., T’Syen, D., Moechars, D., Śliwińska, M. A., Pradhan, B., Albertini, G., Baligács, N., Tsaka, G., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2516774123 · Cited by 1
Cochet, M. (2011) · theses.fr (ABES) · doi:10.70675/599a8bbez3c0bz407dzbd52z0872ed5f8f6d · Cited by 1
Mahmoudi, A.-E.-R. (2015) · theses.fr (ABES) · doi:10.70675/5f05520ez1713z4991za6c8z055ab117e2bb
Drug Discovery for Alzheimer’s Disease: Current Status
Wolfe, M. S. (2026) · Topics in medicinal chemistry · doi:10.1007/7355_2026_186
Hanbouch, L. (2017) · theses.fr (ABES) · doi:10.70675/c4d2c894zf69dz4ae4z9ab1zf4135d0efa12
Boudet-Devaud, F. (2018) · theses.fr (ABES) · doi:10.70675/111341b9z5eeez4531z8f07zcb44d6f469a0
Characterisation of non-covalent PrP assemblies
Bohl, J. (2019) · theses.fr (ABES) · doi:10.70675/2a939bf5z2532z4002z8f02zb15095f2657e
Arnould, H. (2019) · theses.fr (ABES) · doi:10.70675/9f070729z72aez4fccz9604z8c52be1a62e6
Physiological and pathological roles of the amyloid precursor protein at the presynapse
Jordá-Siquier, T. (2021) · theses.fr (ABES) · doi:10.70675/3bff9a77z3935z4d28zb02bz5b454bcbc77e
Freyssin, A. (2020) · theses.fr (ABES) · doi:10.70675/0db2e37dz547bz4731z852dz9b843c062cba
Investigating the physiological function of the amyloid precursor protein in Drosophila melanogaster
Kesisoglou, E. (2020) · theses.fr (ABES) · doi:10.70675/691831c4z5491z4cb9zb88az10456e67b7ce
Ismeurt, C. (2021) · theses.fr (ABES) · doi:10.70675/159d4638zb5f8z4580zb26fzd0419dba4d37 · Cited by 1
Advancements in the Study of Missense Mutations in ABCA7 in Alzheimer’s Disease
Liu, L., & Zhu, B. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-026-02526-9
“…encode core components of the γ-secretase com - plex, and their missense mutations account for the majority of familial EOAD cases, with PSEN1 mutations typically causing more severe clinical phenotypes and PSEN2 mutations exhibiting incomplete penetrance (Scheuner et al. 1996, Mann et al. 1996).”
4-methylumbelliferone attenuates amyloid pathology and learning deficits in the APP/PS1 mouse model
Amontree, M., O’Leary, J., Wonnenberg, P. M., Nelson, M., & Conant, K. E. (2026) · Scientific Reports · doi:10.64898/2026.05.21.726929
Hypertrophic Cardiomyopathy and Sudden Cardiac Arrest Associated with a PSEN1 Variant: A Case Report
INAGAKI, N., Takei, Y., 鴨志田淳一, Shimizu, S., Kosuge, H., Terasawa, M., Kiribayashi, K., Yazaki, Y., Satomi, K., & Hayashi, T. (2026) · Internal Medicine · doi:10.2169/internalmedicine.7239-26
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.05
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.references
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.07
Third Section: Design of a dimeric-nanobody specific for Aβ42 oligomers: the Dimeric-DesAb-O
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.06
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.03
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.04
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.02
Conclusion and Future Perspectives
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.08
Sadhukhan, D., Mukherjee, A., Kamal, I. M., Maitra, S., Vedeshachaitanya, B. S., Bhattacharyya, B., Biswas, A., Chakrabarti, S., & Biswas, A. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01929-2
“The Val717Ile variant is known to alter amyloid precursor protein processing, resulting in an increased Aβ1–42/Aβ1–40 ratio and subsequent accumulation of aggregation-prone Aβ species, thereby contributing to its pathogenicity (Scheuner et al. 1996).”
Brain multiomic profiling identifies tau-related transcriptomic dysregulation in Alzheimer’s disease
Oatman, S. R., Quicksall, Z., Wang, X., Bergman, J., Reddy, J. S., Vanelderen, F., Nguyen, T., Malphrus, K. G., Lincoln, S., Martens, Y. A., et al. (2026) · Brain Communications · doi:10.1093/braincomms/fcag326
AHA1 Regulates Aβ Production via Modulation of APP Abundance and γ‐Secretase Assembly
Noorani, A. A., Islam, S., Filip, E., Catalfano, K. C., Paswan, S. K., Nagarajan, V., Wilkins, H., Blagg, B. S. J., Zou, K., & Wolfe, M. S. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70544
The Crosstalk Between Diabetes and Alzheimer's Disease: A Molecular Perspective
Çataklı, D., Özen, Ö., Tuncgovde, E. B., & Ozsarlak‐Sozer, G. (2026) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70294
Campbell, A., Becker, L., Kreimer, S. D., Gonzales, M., Raedschelders, K., & Eyk, J. E. V. (2026) · Research Square · doi:10.21203/rs.3.rs-11053241/v1
BindingDB (2012) · UC San Diego · doi:10.7270/q27s7pgx
BindingDB Entry 50034093: Aminothiazoles as¿-secretase modulators.
BindingDB (2012) · UC San Diego · doi:10.7270/q2qz2bcm
Molekulargenetik und Molekularbiologie der Alzheimer-Krankheit
Sandbrink, R., & Beyreuther, K. T. (1999) · Springer eBooks · doi:10.1007/978-3-642-60175-0_7
Potential biomarkers for Alzheimer's disease and mild cognitive impairment
Mitchell, M. B. (2009) · Cited by 1
γ-Secretase And Alzheimer’S Disease
Wolfe, M. S. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6311-4_6
“Nevertheless, it became clear that the Alzheimer mutations in the presenilins alter A production (Citron et al., 1997; Duff et al., 1996; Lemere et al., 1996; Scheuner et al., 1996).”
BackgroundMorbus Alzheimer — Epidemiologie, Diagnose und Therapie
Tropp, S., Vitzthum, K., Mache, S., Kusma, B., Schöffel, N., Uibel, S., Groneberg, D. A., & Quarcoo, D. (2010) · Zentralblatt für Arbeitsmedizin Arbeitsschutz und Ergonomie · doi:10.1007/bf03344264
Die Alzheimer-Krankheit: Molekulare Grundlagen und Therapieansätze
Finckh, U., Höck, C., & Nitsch, R. M. (2004) · Springer eBooks · doi:10.1007/978-3-642-18741-4_6
Synapses and Alzheimers’s Disease: Effect of Immunotherapy?
Denham, N. C., Nicoll, J. A. R., & Boche, D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7061-9_14
Alzheimer%#x2019;s Disease and Genetically Engineered Animal Models
Borchelt, D., Wong, P. C., Sisodia, S. S., & Price, D. L. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4887-4_9
Inflammatory proteins in the CNS-relation to Alzheimers disease
Lindberg, C. (2005) · Figshare
Wang, H. (2012) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.14459
Alzheimer’s Disease: A Matter of Dominance
Hardy, J., & Hutton, M. L. (1998) · Springer eBooks · doi:10.1007/978-3-642-72103-8_2
Self-citationPrice (1999) · doi:10.1002/1531-8249(199903)45:3
(1999) · doi:10.1002/1531-8249(199904)45:4<537::aid-ana20>3.0.co;2-2
Self-citationKhan (2000) · doi:10.1002/1531-8249(200008)48:2
Nakagawa (1999) · doi:10.1002/(sici)1096-9861(19990830)411:3
A unifying hypothesis of alzheimer’s disease: III—Risk factors
Heininger, K. (2000) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/(sici)1099-1077(200001)15:1<1::aid-hup153>3.0.co;2-1
(1998) · doi:10.1002/(sici)1098-1004(1998)11:6
Metadata
- Authors
- Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, L., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D., & Younkin, S.
- Affiliations
- Case Western Reserve University (US)
- Mayo Clinic (US)
- Karolinska Institutet (SE)
- Brigham and Women's Hospital (US)
- Takeda (Japan) (JP)
- University of Washington (US)
- University of South Florida (US)
- Harvard University (US)
- ORCID
- Venue
- Nature Medicine
- Published
- 1996-08
- Volume
- 2
- Issue
- 8
- Pages
- 864-870
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2101077392
- Semantic Scholar
- ce2164647cb7fb8dcec21d95359a92ec9830047a
- Cited by
- 2,599
- References
- 40
- Citations by year
- 2026: 26 · 2025: 34 · 2024: 58 · 2023: 74 · 2022: 45 · 2021: 66 · 2020: 66 · 2019: 58 · 2018: 53 · 2017: 64 · 2016: 76 · 2015: 72 · 2014: 77 · 2013: 91 · 2012: 96
- FWCI
- 102.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, familial Alzheimer's disease, presenilin 1, presenilin 2, amyloid precursor protein, APP mutations, amyloid plaques
- MeSH terms
- Alzheimer Disease, Cells, Cultured, Female, Fibroblasts, Humans, Male, Membrane Proteins, Mutation, Peptide Fragments, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Culture Media, Conditioned, Presenilin-1, Presenilin-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.